लोड हो रहा है...

Combination therapy using oral S-1 and targeted agents against human tumor xenografts in nude mice

In this study, combination therapies using the oral fluoropyrimidine tegafur-gimeracil-oteracil (S-1) with several targeted agents or antibodies, were evaluated. First, the effects of tyrosine kinase inhibitors (erlotinib hydrochloride, sorafenib tosilate and sunitinib malate) against human non-smal...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: NUKATSUKA, MAMORU, SAITO, HITOSHI, NAKAGAWA, FUMIO, TSUJIMOTO, HIROAKI, SAKAMOTO, KAZUKI, TSUKIOKA, SAYAKA, UCHIDA, JUNJI, KINIWA, MAMORU, KOBUNAI, TAKASHI, TAKECHI, TEIJI
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: D.A. Spandidos 2012
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC3438730/
https://ncbi.nlm.nih.gov/pubmed/22969964
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2012.484
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!